A Pilot Study of Rare Renal Amyloidosis Based on FFPE Proteomics
Open Access
- 29 November 2021
- Vol. 26 (23) , 7234
Abstract
Renal amyloidosis typically manifests albuminuria, nephrotic-range proteinuria, and ultimately progresses to end-stage renal failure if diagnosed late. Different types of renal amyloidosis have completely different treatments and outcomes. Therefore, amyloidosis typing is essential for disease prognosis, genetic counseling and treatment. Thirty-six distinct proteins currently known to cause amyloidosis that have been described as amyloidogenic precursors, immunohistochemistry (IHC) or immunofluorescence (IF), can be challenging for amyloidosis typing especially in rare or hereditary amyloidosis in clinical practice. We made a pilot study that optimized the proteomics pre-processing procedures for trace renal amyloidosis formalin-fixed paraffin-embedded (FFPE) tissue samples, combined with statistical and bioinformatics analysis to screen out the amyloidosis-related proteins to accurately type or subtype renal amyloidosis in order to achieve individual treatment. A sensitive, specific and reliable FFPE-based proteomics analysis for trace sample manipulation was developed for amyloidosis typing. Our results not only underlined the great promise of traditional proteomics and bioinformatics analysis using FFPE tissues for amyloidosis typing, but also proved that retrospective diagnosis and analysis of previous cases laid a solid foundation for personalized treatment.Keywords
This publication has 33 references indexed in Scilit:
- Proteomic Detection of Immunoglobulin Light Chain Variable Region Peptides from Amyloidosis Patient BiopsiesJournal of Proteome Research, 2015
- AL AmyloidosisOrphanet Journal of Rare Diseases, 2012
- Laser microdissection and mass spectrometry–based proteomics aids the diagnosis and typing of renal amyloidosisKidney International, 2012
- Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsiesKidney International, 2010
- Classification of amyloidosis by laser microdissection and mass spectrometry–based proteomic analysis in clinical biopsy specimensBlood, 2009
- Leukocyte chemotactic factor 2: A novel renal amyloid proteinKidney International, 2008
- New advances in renal amyloidosisClinical and Experimental Nephrology, 2008
- The systemic amyloidosesCurrent Opinion in Rheumatology, 2004
- Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosisCurrent Opinion in Nephrology and Hypertension, 2002
- Human lysozyme gene mutations cause hereditary systemic amyloidosisNature, 1993